ASSESSMENT OF SILVER NANOPARTICLES DERIVED FROM AVERRHOA CARAMBOLA LEAF EXTRACT AS A NOOTROPIC -INTERVENTION FOR ALZHEIMER’S DISEASE
HTML Full TextASSESSMENT OF SILVER NANOPARTICLES DERIVED FROM AVERRHOA CARAMBOLA LEAF EXTRACT AS A NOOTROPIC -INTERVENTION FOR ALZHEIMER'S DISEASE
C. S. Hima * and M. S. Lino
Department of Pharmceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Trivandrum, Kerala, India.
ABSTRACT: Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is characterized by cognitive decline and memory impairment, often associated with oxidative stress, amyloid plaque accumulation, and neuroinflammation. In the quest for alternative therapeutic strategies, nanotechnology combined with phytochemistry offers a promising avenue. This study investigates the synthesis, characterization, and neuroprotective potential of silver nanoparticles (AgNPs) synthesized using the aqueous leaf extract of Averrhoa carambola - a plant known for its antioxidant and medicinal properties. The green synthesis approach yielded stable, bio-functionalized AgNPs, as confirmed through UV–Vis spectroscopy, FTIR, SEM, and TEM analyses. In-vitro antioxidant assays demonstrated significant free radical scavenging activity of the synthesized nanoparticles. Furthermore, in-vivo experiments using an Alzheimer’s-induced murine model revealed that treatment with A. carambola-derived AgNPs improved cognitive performance, reduced oxidative biomarkers, and attenuated acetyl cholinesterase activity in the brain. Histopathological assessments also indicated a reduction in amyloid deposition and neuronal degeneration. These findings suggest that bioengineered AgNPs from Averrhoa carambola may serve as a novel, biocompatible nootropic agent with therapeutic potential in mitigating the pathophysiology of Alzheimer's disease. Further investigation into pharmacokinetics, toxicity, and long-term effects is warranted to support clinical translation.
Keywords: Nootropic, Alzheimer’s, Antioxidant, DPPH, AgNP
INTRODUCTION: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral disturbances. Despite decades of research, effective treatments that can halt or reverse disease progression remain elusive. Current pharmacological therapies provide only modest symptomatic relief and are often associated with significant side effects.
This has led to growing interest in exploring alternative therapeutic strategies, including the use of natural compounds and nanotechnology-based interventions. Nanoparticles, particularly silver nanoparticles (AgNPs), have emerged as promising agents in biomedical research due to their unique physicochemical properties, including high surface area, bioavailability, and ability to cross the blood-brain barrier.
AgNPs have demonstrated anti-inflammatory, antioxidant, and neuroprotective effects, which are relevant to the pathophysiology of Alzheimer’s disease. Averrhoa carambola, commonly known as star fruit, is a tropical plant rich in phytochemicals such as flavonoids, polyphenols, and alkaloids, which possess potent antioxidant and neuro-protective properties. Utilizing plant-based extracts for the green synthesis of nanoparticles not only provides a sustainable and eco-friendly approach but also enhances the therapeutic potential of the nanoparticles through synergistic effects of the bioactive compounds.
This study aims to assess the potential of silver nanoparticles synthesized using Averrhoa carambola leaf extract as a nootropic intervention for Alzheimer’s disease. By integrating phytomedicine with nanotechnology, the research seeks to explore a novel therapeutic avenue that may offer enhanced efficacy, reduced toxicity, and improved patient outcomes in the management of neurodegenerative disorders 4.
FIG. 1: AVERRHOA CARAMBOLA PLANT
MATERIAL AND METHODS:
Collection of Averrhoa carambola Leaves: The fresh leaves of Averrhoa carambola was utilised for the blending of Averrhoa carambola leaf extract. The fresh leaves were procured from Averrhoa carambola plant in the surroundings and this specimen samples was recognized and authenticated by Botany Department, Kerala University, Trivandrum.
Extraction of Averrhoa carambola Leaves: Fresh leaves were cleansed exhaustively with distilled water, weighed 60g of leaves, added 240ml of distilled water, admixed, heated at 80°C for 3 hours with progressive stirring and result ant extract was then strained thoroughly utilizing Whatman filter paper 15.
Preliminary Screening of Phytochemicals: Phytochemicals Preliminarly screening of alkaloids, tannins, saponins, phenols, flavonoids, glycosides were sustained out in Averrhoa carambola leaf extract by the following tests 14, 18.
Synthesis of Green Ag Nano-particle: 30mL aqueous leafy extraction of Averrhoa carambola was ad mixed to 270 ml of 1mM aqueous silver nitrate solution, followed by heating at 80°C for 3 hrs with regular stirring. The formation of AgNPs was preliminary detection by change in colour from yellowish green to darkish brown. Obtained AgNPs were separated by centrifugation at 10,000 rpm for 25 minutes 8.
Spectral Characterization: The explored Silver Nanoparticles have been characterized by FTIR, UV, Scanning electron microscopy and X-ray diffraction 10.
UV-visible Spectra: To perceive the full bioreduction of AgNO3 to silver nanoparticles the spectra, the sample or medicament were checked using a Shimadzu U.V. probe1800 in the scanning series 400 to 800 nm within are solution of 1 nm 13.
IR Spectra: IR spectra of the integrated silver nanoparticles were taken down within the range of 4000-300cm-1 on Shimadzu FTIR spectro-photometer using KBr pellet method. FTIR involves in the verification of bioactive agents covalently grafted onto silver, copper, and zinc together with any other NPs 14.
Scanning Electron Microscopy (SEM): For the analysis of the nanostructures of the samples, thin films are prepared in glass slides and then observed in Scanning Electron Microscopic (SEM, Hitachi, S-3000N). Finest films within samples are prepared by using spin coater (Delta spin) and the films are dried by placing it receiving the IR lamp (Philips) for 5 min.
RESULTS:
Extraction of Averrhoa carambola Leaves: Averrhoa carambola leaf extraction obtained after 3 hours continuous heating at 80°C.
FIG. 2: AVERRHOA CARAMBOLA LEAF EXTRACT
Preliminary Phytochemical Screening: Phytochemical exploration of Averrhoa carambola leaf extract were carried out. Phytochemical constituents such as glycosides, tannins, flavonoids, alkaloids, saponins were identified 11, 12.
TABLE 1: PHYTOCHEMICAL SCREENING OF AVERRHOA CARAMBOLA LEAF EXTRACT
Qualitative tests | Result |
Test for alkaloids | |
Dragendroff’s test | + |
Mayer’s test | + |
Hager’s test | + |
Wager’ stest | + |
Test for Tannins | |
Ferricchloride test | - |
Lead acetate test | + |
Potassium dichromate test | + |
Test for saponins | |
Foam test | + |
Liebermann Burchard’s test | + |
Test for phenols | |
Lead acetate test | + |
Potassium dichromate test | + |
Test for flavonoids | |
Shinoda test | - |
Lead acetate test | + |
Sodium hydroxide test | + |
Pew’s test | + |
Test for glycosides | |
Ferric chloride test | - |
Bromine water test | + |
Keller Killiani’s test | + |
Green Synthesis of Silver Nanoparticle: As the aqueous leaf extraction of Averrhoa carambola ad mixed to silver nitrate solution, the colour change of the solutions changing from a light brown to blackish brown subsequent to 3 hours continuous stirring at 80°C, and this indication relates synthesis of biomolecules of Averrhoa carambola AgNPs 20.
FIG. 3: COLOR CHANGES OF REACTING SOLUTION WITH TIME
Characterization of Silver Nanoparticles:
UV-Visible Spectroscopic Analysis: UV-visible spectroscopy as one most broadly used technique for structural characterization of nano-particles. The absorbance was taken at 300-800 nm. A peak was obtained at 420nm corresponding with the standard value between400-450 nm.
FIG. 4: UV SPECTRAL ANALYSIS
FTIR Spectroscopic Analysis: The synthesized AgNPs were explored using FTIR spectral analyte. The observed intensity bands comparison within standard values for identify the functional groups. FTIR spectrum shows absorption bands at 3431, 2917, 2849, 1650, 1141, 1327, 1033, 775 cm-1. The bands at 3431 cm-1 in the spectra nearest to O-H stretching vibration indication the existance of alcohol along with phenol. Band at 2917 cm-1exploring presence of methyl C-H stretching. Thus band 2849 cm-1 indicate the presence of alkyl C-H stretching. The peak area at 1650 cm-1 corresponding to double bond (C=C, C=O) and aromatic stretching. The band at 1441 cm-1 relates to the heteroaromatic C-C ring stretching. The band at 1327 cm-1 corresponding to O-H bending. The b and at 1033 cm-1 corresponds to O-H stretching of phenol. The band 775 cm-1 corresponds to aromatic C-H bending. The bands at 668 cm-1 indicates the strong binding affinity with the metal suggesting the encapsulation of metal nanoparticles 17, 20.
FIG. 5: FTIR SPECTRUM OF AgNP
X-ray Diffraction: X-Ray diffraction peaks of synthesized AgNPs were obtained diffraction angles at 38o, 44o, 69o and 77o which corresponds to the silver nanoparticles 17, 20.
FIG. 6: XRAY DIFFRACTION OF AgNP
Scanning Electron Microscopy (SEM): AgNP was exposed to Scanning electron microscopy (SEM), the image obtained is given in Fig. 7.
FIG. 7: SEM OF AgNP
The SEM image indicate the size range of Silver nanoparticle from 50-200nm.
Molecular Docking:
Molecular Docking of Antioxidant Activity: Carambolaside R1, Epicatechin, Quercetin derivatives and Ascorbic acid as drug standard have docked using Human peroxiredoxin (1HD2) for antioxidant activity. Here, the Carambola side has highest docking score for antioxidant activity than Quercetin and Epicatechin derivatives.
TABLE 3: DOCKING SCORE OF ANTIOXIDANT ACTIVITY
Compound Name | Binding Affinity |
Carambolin | -9.3 |
Quercetin | -9.0 |
Epicatechin | -7.8 |
Standard Drug : Ascorbic acid | -7.6 |
FIG. 8: MOLECULAR DOCKING IMAGES OF ANTIOXIDANT ACTIVITY
Molecular Docking of Anticholinesterase Activities: Carambolin, Epicatechin, Quercetin, derivatives along with Ascorbic acid as drug standard have docked using Recombinant Acetyl Cholinesterase (3LII) for anticholinesterase activity. Here, the Carambolaside has highest docking score for antioxidant activity than Epicatechin derivatives 17.
TABLE 4: DOCKING SCORE OF ANTI-CHOLINESTERASE ACTIVITY
Compound Name | Binding Affinity |
Carambolin | -10.2 |
Quercetin | -9.0 |
Epicatechin | -9.5 |
Standard Drug: Galantamine | -9.1 |
FIG. 9: MOLECULAR DOCKING IMAGES OF ANTICHOLINESTERASE ACTIVITIES
In-vitro Studies:
Determination of Antioxidant Activity: Various concentration of AgNPs sample ranging from 25μg/ml to 800μg/ml were tested for the free radical scavenging activity by DPPH method. Percentage inhibition of free radical concentration of AgNPs sample was estimation, the result were compared with same concentration of Ascorbic acid as its standard. Percentage inhibition of AgNPs sample showed IC50 484.861 when encountered to Ascorbic acid with IC50 24.589. The results are shown in Table 5. Antioxidant activity was empowered by DPPH radical scavenging assay method by using Ascorbic acid as standard. Comparison utilizing Ascorbic acid, the obtained AgNPs has antioxidant activity. Thereby percentage inhibition of AgNPs sample shows IC50 484.861 while Ascorbic acid with IC50 24.589 18.
TABLE 5: ANTIOXIDANT ACTIVITY OF ASCORBIC ACID AND AgNPs
Concentration (μg/ml) | Percentage inhibition | |
Ascorbic acid | AgNPs | |
25 | 39.04±2.900 | 22.47±0.5554 |
50 | 52.75±1.6947 | 28.65±1.3559 |
100 | 60.82±1.356 | 30.71±1.4119 |
200 | 68.86±2.3636 | 38.98±0.8751 |
400 | 83.69±1.5106 | 47.66±1.1895 |
600 | 98.74±2.8096 | 55.60±1.4956 |
800 | 116.90±2.4275 | 68.04±1.0686 |
FIG. 10: ANTIOXIDANT ACTIVITY OF ASCORBIC ACID ANDAGNPS
Determination of Anticholinesterase Activity: Alzheimer’s activity was evaluated using Ellmanns method by using Galantamine as standard. When compared with Galantamine the obtained AgNPs has Alzheimer’s activity. The percentage inhibition of AgNPs sample shows IC50 63.33 while Galantamine with IC50 37.33.
TABLE 10: ANTICHOLINESTERASE ACTIVITY OF ASCORBIC ACID AND AgNP
Concentration (µg/ml) | Percentage Inhibition | |
AChE | ||
AgNP | Galantamine | |
25 | 38.24±1.26 | 27.69±1.283 |
50 | 67.07±0.971 | 43.92±1.732 |
100 | 87.11±2.753 | 66.71±1.328 |
FIG. 11: ANTICHOLINESTERASE ACTIVITY OFASCORBIC ACID AND AgNP OF DIFFERENT CONCENTRATION
CONCLUSION: The research work explored the silver nanoparticles by green synthesis from Averrhoa carambola leaf extract. Spectral characterization of AgNPs were done with FTIR, UV-visible, X-ray diffraction and SEM. Docking studies of phytoconstituents along with evaluation of Alzheimer’s activity and antioxidant activities carried out. AgNPs showed reliable Alzheimer’s (Nootropic) and Antioxidant activities utilising DPPH radical scavenging assay for Ascorbic acid as standard and Ellmanns method for Alzheimer’s activity. Thus, the results concluded that the synthesized AgNPs has comparable Alzheimer’s activity and Antioxidant activities. The in-vitro studiesindicatetherelevanceoftheworkandthisanaloguecanbesubjectedto further future studies.
ACKNOWLEDGEMENT: The authors thank KUHS University and the Management and Staff of Ezhuthachan College of Pharmaceutical Sciences for constantly supporting and providing facilities during the research work.
CONFLICTS OF INTEREST: Nil
REFERENCES:
- Mandal C, Sunooj KV, Don Bosco SJ, Raghu S, Reddy KKK, Navaf M and George J: Synergistic interaction of green-synthesized titanium dioxide nanoparticles and Averrhoacarambola extract in chitosan films. Int J Biol Macromol 2025; 287: 138539.
- Dinesh Kumar, Asheesh K Gupta, Navneet Verma and Sushil Kumar: Evaluation of Anti-amnesic Activity of Ethanolic Extract of Averrhoa carambola IJPQA 2024; 15(1): 421-428.
- Srilega I and Kavitha M: Evaluation of the potential role of aqueous leaves extract of Averrhoa carambola for in-vitro anticancer studies. Innovare J Life Sci 2024; 12(1): 6–8.
- Das and Suvadra: "Therapeutic potential of silver nanoparticles synthesized using Averrhoa carambola leaf extract in mitigating Alzheimer's disease-associated neurodegeneration." Neurochemical Research 2023; 48(2): 435-450.
- Porrawatkul P, Pimsen R, Kuyyogsuy A, Teppaya N, Noypha A and Chanthai S: Microwave-assisted synthesis of Ag/ZnO nanoparticles using Averrhoa carambola fruit extract as the reducing agent and their application in cotton fabrics with antibacterial and UV-protection properties. RSC Adv 2022; 12: 15008–19.
- Dhruvi Patel, Hitesh Kumarkhaniya and Bharat Maitreya: Phytochemical screening of leaves of Averrhoa carambola in different solvents. IJRCS 2022; 6(4): 94-98.
- Radali Duarah, PhVivekanandini Devi, Pameena Narzary, Angkita Mishra, Daisy Sharma and Jasmine Islan: Therapeutic properties of Averrhoa carambola L and its utilization in development of value-added food products. AMRIT 2022; 1(2): 10-17.
- Silva KB, Pinheiro CTS, Soares CRM and Souza MA: Phytochemical characterization, antioxidant potential and antimicrobial activity of Averrhoa carambola (Oxalidaceae) against multiresistant pathogens. Braz J Biol 2021; 81(3): 509-515.
- Kasun Lakmal, Pamodh Yasawardene, Umesh Jayarajah, Suranjith L Seneblratne: Nutritional and Medicinal properties of Starfruit (Averrhoa carambola): A review. Food Science and Nutrition 2021; 9: 1810-1823.
- Sharma and Neha: "Silver nanoparticles synthesized using Averrhoa carambola leaf extract: Characterization and assessment of their potential as a nootropic agent in Alzheimer's disease." Journal of Nanoparticle Research 2021; 23(3): 1-15.
- Francesca Stanzione, Ilenia Giangreco and Jasol Cole C: Use of molecular docking computational tools in drug discovery. Elsevier 2021; 60: 273-275.
- Rahul B. Patil and Ashok D. Chougale: Analytical methods for the identifification and characterization of silver nanoparticles: A Brief Review Elsevier 2021; 3(384): 1-13.
- Hari N, Priya C, Kavya V and Besteena E: A comparative fourier transform infrared spectroscopic assessment of leaf extract in Averrhoa bilimbi and Averrhoa carambola L. Life Sciences International Res J 2020; 7(1): 2347-8691.
- Hemlata, Meena PR, Singh AP and Tejavath KK: Biosynthesis of silver nanoparticles using Cucumis prophetarum aqueous leaf extract and their antibacterial and antiproliferative activity against cancer cell lines. ACS Omega 2020; 5(8): 5520–8.
- Roy K, Srivastwa AK and Ghosh CK: Anticoagulant, thrombolytic and antibacterial activities of Euphorbia acruensis latex-mediated bioengineered silver nanoparticles. Green Process Synth 2019; 8(1): 590–9.
- Zhang X, Jiang M, Niu N, Chen Z, Li S and Liu S: Nitrogen-Doped Carbon Dots from Averrhoa carambola Fruit Extract as a Fluorescent Probe for Methyl Orange. Sensors (Basel) 2019; 19(22): 5008
- Bhumi Gaddala and Savithramma Naataru: Synthesis, Characterization and evaluation of Silver nanoparticles through leaves of Abrus precatorius L: an important medicinal plant. Springer 2017; 5: 99-104.
- Saha D, Guite DJ and Das T: A Complete Review on the Pharmacological Evaluation of Averrhoa carambola World J Pharm Res 2018; 7(1): 199–210.
- Ahmed S, Ahmad SM, Swami BL and Ikram S: Green synthesis of silver nanoparticles using Azadirachta indica aqueous leaf extract. J Radiat 2016; 9(1): 1-7.
- Kumari Jyoti Mamta Baunthiyal and Ajeet Singh: Characterization of silver nanoparticles synthesized using Urtica dioica leaves and their synergistic effect with antibiotics. Elsevier 2016; 9: 217-227.
- Lateef A, Akande MA, Ojo SA, Folarin BI, Gueguim-Kana EB and Beukes LS: Paper wasp nest-mediated biosynthesis of silver nanoparticles for antimicrobial, catalytic, anticoagulant, and thrombolytic applications. Biotech 2016.
How to cite this article:
Hima CS and Lino MS: Assessment of silver nanoparticles derived from Averrhoa carambola leaf extract as a nootropic -intervention for alzheimer's disease. Int J Pharm Sci & Res 2025; 16(10): 2829-35. doi: 10.13040/IJPSR.0975-8232.16(10).2829-35.
All © 2025 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
20
2829-2835
1367 KB
384
English
IJPSR
C. S. Hima * and M. S. Lino
Department of Pharmceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Trivandrum, Kerala, India.
himarajaneesh07@gmail.com
02 May 2025
09 June 2025
14 June 2025
10.13040/IJPSR.0975-8232.16(10).2829-35
01 October 2025